Supplementary Table S2. Drug Burden Index (DBI) medications included in a previous study in the USA20 but not included in the master DBI list Medications not included in master DBI list Reason for non-inclusion in master DBI list Astemizole Not licensed in Ireland Azatadine Not licensed in Ireland Belladonna Not licensed in Ireland Benzonatate Not licensed in Ireland Butalbital Not licensed in Ireland Carisoprodol Not licensed in Ireland Chlorprothixine Not licensed in Ireland Chlorzoxazone Not licensed in Ireland Clidinium Not licensed in Ireland Clorazepate Not licensed in Ireland Cyclobenzaprine Not licensed in Ireland Desipramine Not licensed in Ireland Dexbrompheniramine Not licensed in Ireland Dextromethorphan Does not meet study definitions for DBI medication Dichloralphenazone Not licensed in Ireland Estalozam Not licensed in Ireland Guanabenz Not licensed in Ireland Guanethidine Not licensed in Ireland Guanfacine Not licensed for use in the elderly in Ireland Hexobarbital Not licensed in Ireland Hydrocodone Not licensed in Ireland Loperamide Does not meet study definitions for DBI medication Meprobamate Not licensed in Ireland Metaxalone Not licensed in Ireland Methscopolamine Not licensed in Ireland Nefazodone Not licensed in Ireland Opium Not licensed in Ireland Papaverine Not licensed in Ireland Pheniramine Not licensed in Ireland Phenyltoloxamine Not licensed in Ireland Propoxyphene Not licensed in Ireland Reserpine Not licensed in Ireland Selegiline Does not meet study definitions for DBI medication Tamsulosin Does not meet study definitions for DBI medication Thioridazine Not licensed in Ireland Tranylcypromine Does not meet study definitions for DBI medication Triflupromazine Not licensed in Ireland Trimethobenzamide Not licensed in Ireland Tripelennamine Not licensed in Ireland